Somerville, MA, United States of America

Daniel A Snyder

This inventor holds 34 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 9 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Infinity Pharmaceuticals, Inc., Infinity Discovery, Inc., Massachusetts Institute of Technology. Active years: 2010-2017.

USPTO Granted Patents = 34 (Patent Applications = 7)

% Patents Active = 29.4

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 7.8

ph-index = 8

Forward Citations = 297(Granted Patents)

Location History:

Cambridge, MA (US) (2010 - 2011)
Somerville, MA (US) (2011 - 2017)

Company Filing History:

29 out of 108

Infinity Pharmaceuticals, Inc.

patents

3 out of 12

Infinity Discovery, Inc.

patents

1 out of 8,576

Massachusetts Institute of Technology

patents

4. 1 out of 834,411

Other

patents

Years Active: 2010-2017

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Fatty Acid Amide Hydrolase

Inhibitors

Tetrazolones

Isoxazolines

BCL Proteins

Monoacylglycerol Lipase

Fatty Acid Synthase

Substituted Isoquinolinones

Glycosylphosphatidylinositol Glycans

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9718815 - Heterocyclic compounds and uses thereof (2017-08-01),

2. 9630979 - Inhibitors of monoacylglycerol lipase and methods of their use (2017-04-25),

3. 9605003 - Heterocyclic compounds and uses thereof (2017-03-28),

4. 9546180 - Heterocyclic compounds and uses thereof (2017-01-17),

5. 9388183 - Heterocyclic compounds and uses thereof (2016-07-12),

6. 9346769 - Tetrazolones as inhibitors of fatty acid synthase (2016-05-24),

7. 9255108 - Heterocyclic compounds and uses thereof (2016-02-09),

8. 9149465 - Isoxazolines as inhibitors of fatty acid amide hydrolase (2015-10-06),

9. 9115141 - Substituted isoquinolinones and methods of treatment thereof (2015-08-25),

10. 9108989 - Inhibitors of fatty acid amide hydrolase (2015-08-18),

11. 9056877 - Heterocyclic compounds and uses thereof (2015-06-16),

12. 8969363 - Heterocyclic compounds and uses thereof (2015-03-03),

13. 8957049 - Inhibitors of fatty acid amide hydrolase (2015-02-17),

14. 8940742 - Heterocyclic compounds and uses thereof (2015-01-27),

15. 8927551 - Isoxazolines as inhibitors of fatty acid amide hydrolase (2015-01-06),

Title: The Innovative Journey of Daniel A. Snyder

Introduction: Daniel A. Snyder, a talented inventor based in Somerville, MA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Daniel A. Snyder holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a background in computer science and engineering, Daniel A. Snyder has a successful career marked by a series of innovative projects. He has worked for leading tech companies, where he played a key role in developing cutting-edge technologies that have shaped the industry.

Collaborations: Throughout his career, Daniel A. Snyder has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions. His collaborative efforts have resulted in the creation of groundbreaking solutions that have had a lasting impact on the tech landscape.

Conclusion: Daniel A. Snyder's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit continues to drive him towards creating solutions that push the boundaries of what is possible in the ever-evolving tech industry.